{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "51662-1642",
      "generic_name": "Narcan Naloxone HCL",
      "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst",
      "brand_name": "Narcan Naloxone HCL",
      "active_ingredients": [
        {
          "name": "NALOXONE HYDROCHLORIDE",
          "strength": "4 mg/.1mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "51662-1642-2",
          "description": "2 VIAL, SINGLE-DOSE in 1 CARTON (51662-1642-2)  / .1 mL in 1 VIAL, SINGLE-DOSE (51662-1642-1)",
          "marketing_start_date": "20230828",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "HF Acquisition Co LLC, DBA HealthFirst"
        ],
        "spl_set_id": [
          "11d770b8-b768-ba3d-e063-6394a90a61a6"
        ],
        "unii": [
          "F850569PQR"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "SPRAY",
      "spl_id": "11d770b8-b769-ba3d-e063-6394a90a61a6",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "NASAL"
      ],
      "marketing_start_date": "20230828",
      "product_id": "51662-1642_11d770b8-b769-ba3d-e063-6394a90a61a6",
      "application_number": "NDA208411",
      "brand_name_base": "Narcan Naloxone HCL",
      "pharm_class": [
        "Opioid Antagonist [EPC]",
        "Opioid Antagonists [MoA]"
      ]
    }
  ]
}